戻る
CARsgen Therapeutics Holdings Limited (02171.HK)価格
02171.HK 株価推移チャート
CARSGEN-B (02171.HK)
CARsgen Therapeutics Holdings Limited
HK$15.55
-2.69%
$-0.42
レギュラーマーケット： Jan 20, 14:40:46 HKT
主要データ
前終値
$16
始値
$15.98
当日レンジ
$15.5 - $15.98
52週レンジ
$8.5 - $25.6
取引高
388.5K
平均取引高
1.7M
1株当たり利益(TTM)
-1.06
配当利回り
--
時価総額
$8.5B
CARSGEN-Bとは何ですか？
CARsgen Therapeutics Holdings Ltd. is a clinical-stage biopharmaceutical company, which engages in discovering, researching, and developing cell therapies. The company is headquartered in Shanghai, Shanghai and currently employs 371 full-time employees. The company went IPO on 2021-06-18. The Company’s main business is engaged in developing chimeric antigen receptor T cell (CAR T) -cell therapies to address clinical needs including but not limited to hematologic malignancies solid tumors and autoimmune diseases. The Company’s main products include zevor-cel (zevorcabtagene autoleucel), satricabtagene autoleucel and allogeneic CAR T-cell products. The firm conducts its business in the domestic and overseas markets.